Myomo IncMYO
Price$1.61

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $43.3M+32.9% YoYTTM through 30 Jun 2026
Net Income -$14.5MTTM through 30 Jun 2026
Free Cash Flow -$8.3MTTM through 30 Jun 2026

Margins

Current
Gross Margin68.2%
EBITDA Margin-26.4%
Operating Margin-31.6%
Net Margin-33.5%

Returns

-248.9%ROE
-41.0%ROA

Balance Sheet Health

Debt / Equity1.98x
Current Ratio2.31x
Net Debt-$4.8Mnet cash position
Cash & Equivalents$11.2M

Quality Metrics

Altman Z-Score-3.06
Piotroski F-Score2 / 9
FCF Margin-19.2%
Rule of 40-14.6
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $40.9M
Diluted EPS-$0.34TTM
'21'22'23'24'25
FY2025: $-0.37

Dividend

No dividend

Capital Allocation

R&D Spend$6.5M
Capex Intensity2.8%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.